NewsRack: 'everywhere' news in 'IP' topic for user Genecampaign (7,689-7,709 of 8,497)

Madras High Court dismisses Novartis’ petitions (Cached)	7.8.2007	Hindu: National
CHENNAI: The Madras High Court on Monday dismissed two writ petitions filed by Novartis AG and Novartis India Limited challenging the constitutional validity of Section 3(d) of the Patent (Amendments) Act 2005. (Through a separate ...
Also found in: [+]
Verdict will impact public health (Cached)	7.8.2007	Hindu: National
Huge relief for millions of patients, says NGO; Novartis sees negative consequences
Also found in: [+]
Madras High Court dismisses Novartis’ petitions (Cached)	7.8.2007	Hindu: National
Lawful validity of Section 3(d) of Patent Act challenged
Also found in: [+]
Industry hails Novartis decision (Cached)	7.8.2007	TOI: India
The Glivec case has ensured that the 25,000 new cases of chronic myeloid leukemia that appear in India every year will be able to get treatment at one tenth the cost.
Also found in: [+]
Novartis loses plea; HC upholds Patents Act provision (Cached)	7.8.2007	HBL: Corporate
The Madras High Court on Monday rejected the contention of multi-national pharma major Novartis that the amended law on products eligible for patent is beyond the legislative powers of Parliament. A Division Bench, comprising Mr Justice ...
Also found in: [+]
HC rejects Novartis plea against patent law clause (Cached)	6.8.2007	The Indian Express -- Front Page
The Madras High Court today rejected a challenge by Novartis to a provision in the Indian Patents Act that denies patents for minor improvements to known drugs
Also found in: [+]
Madras-High-Court-spikes-Novartis-patent-challenge (Cached)	6.8.2007	Financial Express: Front Page
The Madras High Court on Monday dismissed a petition filed by Swiss pharmaceutical major Novartis challenging the Patents (Amendment) Act of 2005, under which the company filed a patent application for Glivec. Novartis, in its petition, challenged the validity of Indian patent law, arguing that it stifled innovation.
Also found in: [+]
Experts-feel-judgment-was-on-expected-lines (Cached)	6.8.2007	Financial Express: Front Page
With the Madras High Court rejecting Novartis' challenge of the Indian patent law, experts feel that the HC move was on expected lines. Says YK Hamied, chairman, Cipla, "I have always said that this case should not have come to the Indian courts. It was needless for Novartis to pursue this case for six months and then reach this situation."
Also found in: [+]
HC-ruling-will-dismay-MNC-innovations (Cached)	6.8.2007	Financial Express: Front Page
In the backdrop of the Madras HC's dismissal of its petition challenging the constitutional validity of Section 3(d) of the Indian Patents (amendment) Act 2005, Ranjit Shahani, vice chairman & MD, Novartis India spoke to Reghu Balakrishnan on the impact the verdict can create on the $8 billion Indian pharma industry.
Also found in: [+]
Global relief as court rejects Novartis patent claim (Cached)	6.8.2007	New Kerala: India News

Also found in: [+]
Novartis loses Glivec case, may not move SC (Cached)	6.8.2007	Business Standard
Novartis loses Glivec case, may not move SC
Also found in: [+]
Drug firm suffers India court blow	6.8.2007	BBC South Asia
An Indian court thwarts efforts by Swiss pharmaceuticals firm Novartis to obtain a new patent for a variation of the same drug.
Also found in: [+]
HC rejects Novartis' plea on patent (Cached)	6.8.2007	Rediff: Business
The Madras High Court on Monday dismissed a petition filed by Swiss pharmaceutical major Novartis AG, challenging the constitutional validity of the section 3 (d) of the Patents (Amendment) Act 2005.
Also found in: [+]
Novartis unlikely to appeal Indian patent order (Cached)	6.8.2007	DNA: Top News
Novartis was unlikely to appeal against an Indian court's order rejecting its challenge to Indian law that denies patents for minor improvements to known drugs.
Also found in: [+]
HC rejects petition by Novartis (Cached)	6.8.2007	ET: Pharma
HC dismisses a petition filed by Novartis, challenging the constitutional validity of the Sect 3 (d) of the patents (amendment) act 2005.
Also found in: [+]
Equities seen subdued tracking global cues (Cached)	6.8.2007	ET: Stocks News
Yet another spell of correction looms around the market Monday after a major sell-off in the global markets overnight.
Also found in: [+]
It's D-day for Novartis' Glivec case (Cached)	6.8.2007	ET: Pharma
This case may have a profound impact on patients’ access to generic medicines in India.
Also found in: [+]
Attrition-hit offices get impatent (Cached)	6.8.2007	ET: Jobs
More than one-fifth of patent examiners have quit during last two years.
Also found in: [+]
Final-diagnosis-on-Novartis-patent-suit-likely-today (Cached)	5.8.2007	Financial Express: Front Page
The Madras High Court is set to give its verdict on Monday on Novartis' suit against the Government of India, challenging the provisions of a certain Section in the Indian Patent Act the Trade Related Aspects of Intellectual Property Rights agreement.
Also found in: [+]
India, Pakistan to fight for Basmati (Cached)	5.8.2007	The Statesman
India, Pakistan to fight for Basmati
Also found in: [+]

7,689 to 7,708 of 8,517